Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro 
Neuralink Plans Automated Brain Implant Surgeries and Mass Production by 2026 
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch 
Boeing Secures Multi-Billion Dollar Defense Contracts for F-15IA Jets and E-4B Aircraft Support 
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube 
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts 
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies 
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China 
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital 
Leapmotor Targets 4 Million Annual EV Sales as Global Expansion Accelerates 
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares 
Star Entertainment Leadership Shake-Up Deepens as CFO and COO Exit Amid Ongoing Restructuring 
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round 
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026 
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions 
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms 
BP’s Castrol Stake Sale Raises Debt Relief Hopes but Sparks Cash Flow Concerns 
 Plans of Chicago Bridge & Iron Company N.V. (NYSE:CBI) - EconoTimes)
NEW YORK, March 03, 2017 -- Stull, Stull & Brody today announced that a securities fraud complaint has been filed and that it has commenced an investigation relating to the 401(k) defined contribution plan of Chicago Bridge & Iron Company N.V. ("CBI" or the "Company") (NYSE:CBI). Among other things, Stull, Stull & Brody is investigating whether fiduciaries of CBI's 401(k) plan violated the Employee Retirement Income Security Act of 1974 ("ERISA") by offering CBI stock as an investment option under the plan when it was not prudent to do so and by failing to disclose the Company's true financial and operating condition to participants and beneficiaries of the plan.
If you held CBI stock in an individual account under a Company 401(k) plan during 2013 and 2014 and you have questions about your legal rights or interests with respect to these matters, please contact Michael Klein, Esq. at Stull, Stull & Brody by e-mail at [email protected], by calling toll-free 1-800-337-4983 x147, by fax to 1-212-490-2022, or by writing to Stull, Stull & Brody, 6 East 45th Street, New York, NY 10017. You can also visit our website at www.ssbny.com.
The securities fraud action filed in the U.S. District Court for the Southern District of New York focuses on whether, between October 29, 2013 and December 10, 2014, the defendants failed to disclose that CBI was responsible for hundreds of millions of dollars in liability and had improperly accounted for its goodwill during 2013 to cover losses associated with delays and overruns on the Nuclear Projects. The complaint also alleges CBI failed to establish and disclose an appropriate reserve for this liability and lacked effective internal controls. As a result, CBI stock traded at artificially exaggerated prices of over $87/share during the Class Period, before dropping to under $40/share in late 2014.
You may retain Stull, Stull & Brody, or other counsel of your choice, to represent you. Stull, Stull & Brody has litigated many class actions for violations of securities laws in federal courts over the past 40 years and has obtained court approval of substantial settlements on numerous occasions. Stull, Stull & Brody maintains offices in New York and Beverly Hills.
Attorney Advertising. Prior Results Do Not Guarantee A Similar Outcome.
